...
首页> 外文期刊>Journal of Botany >Biochemical and Histological Evaluation of Three Selected Medicinal Plant Extracts of Sri Lankan Origin on Dyslipidemia and Oxidative Stress in Alloxan Induced Diabetic Rats
【24h】

Biochemical and Histological Evaluation of Three Selected Medicinal Plant Extracts of Sri Lankan Origin on Dyslipidemia and Oxidative Stress in Alloxan Induced Diabetic Rats

机译:斯里兰卡三种药用植物提取物对四氧嘧啶致糖尿病大鼠血脂异常和氧化应激的生化和组织学评价。

获取原文
           

摘要

The objective of the present study was to investigate the effect of refluxed aqueous extracts of Gmelina arborea, Spondias pinnata, and Coccinia grandis on atherogenicity and oxidative stress in rats with chemically induced type 1 diabetes mellitus. Alloxan monohydrate (150 mg/kg, intraperitoneal) was used to induce diabetes to Wistar rats. Thereafter, diabetic rats (n=6 per group) were treated with the three selected plant extracts at their optimum effective therapeutic doses and glibenclamide (0.50 mg/kg, positive control) for 30 days. Administration of the three extracts in diabetic rats exhibited antihyperglycemic, antiatherogenic, and antioxidant effects in diabetic rats on the 30th day of the study. The atherogenic and coronary risk indices were also reduced in support of the antiatherogenic effects. The results of the study revealed that the bark extracts of G. arborea, S. pinnata, and leaf extract of C. grandis exerted beneficial effects against dyslipidemia, atherogenicity, and oxidative stress in alloxan induced diabetic rats. The selected plant extracts would be beneficial for the development of food supplements targeting main complications associated with diabetes.
机译:本研究的目的是研究回流的Gmelina arborea,Spondias pinnata和Coccinia grandis的水提物对化学诱导的1型糖尿病大鼠的动脉粥样硬化性和氧化应激的影响。一水合四氧嘧啶(150 mg / kg,腹膜内)用于诱导Wistar大鼠糖尿病。此后,用三种选择的植物提取物以其最佳有效治疗剂量和格列苯脲(0.50 mg / kg,阳性对照)对糖尿病大鼠(每组n = 6)进行治疗30天。在研究的第30天,在糖尿病大鼠中服用这三种提取物表现出抗降血糖,抗动脉粥样硬化和抗氧化作用。降低了动脉粥样硬化和冠心病危险指数,以支持抗动脉粥样硬化作用。研究结果表明,G。arborea,S。pinnata的树皮提取物和C. grandis的叶提取物对四氧嘧啶致糖尿病大鼠的血脂异常,动脉粥样硬化和氧化应激具有有益的作用。选择的植物提取物将有助于开发针对与糖尿病相关的主要并发症的食品补充剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号